Skip to content

Musculoskeletal Ultrasound Study in Critical Care: Longitudinal Evaluation

Assessment of Peripheral Muscle and Bone Mass in the Critically Ill and Its Response to External Muscle Stimulation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01106300
Acronym
MUSCLE
Enrollment
63
Registered
2010-04-19
Start date
2009-02-28
Completion date
2015-12-31
Last updated
2015-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Organ Failure, Septic Shock, Trauma

Brief summary

Each year, 110,000 English/Welsh patients are admitted to Intensive Care Units (ICU). Many face prolonged disability as a result. Over two thirds have moderate-extreme limitation in their usual activity a year later, and one-third are severely affected, being unable to continue most activities, or to live independently. Quite why known- but severe muscle wasting isn't may play an important role. We hope to find out, measuring the degree of wasting in patients, and seeking potential causes. We shall also address the mechanism of wasting, which may reflect an altered balance of activity in muscle growth pathways and those that break muscle down. We'll do this by collecting data, taking regular blood tests, scanning the leg muscles with an ultrasound machine, and analysing small muscle samples. In addition, we'll accurately and objectively measure how impaired these patients become, using specialist questionnaires, special monitoring equipment, simple walking tests and occasional special ('Cardio-Pulmonary') exercise tests. We'll try to see how badly activity is limited, and tease out whether muscle weakness plays a significant role in this. Finally, keeping muscles working (hard to do when unconscious/drowsy/bed-bound) may maintain muscle mass, so we'll see whether maintaining muscle activity using painless electrical stimulation will help.

Interventions

None listed

Sponsors

King's College London
CollaboratorOTHER
Imperial College London
CollaboratorOTHER
University of Nottingham
CollaboratorOTHER
University College, London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ventilated patients aged \> 18 years likely to survive and remain ventilated for 48 hours and on ICU for 7 days will be recruited.

Exclusion criteria

* Those who are pregnant, * Have active malignancy, * Have primary muscle/bilateral lower limb disorders or * Are unlikely to survive 48 hrs.

Design outcomes

Primary

MeasureTime frameDescription
Cross sectional area of Rectus Femoris10 daysLoss of 15% of Cross sectional area over 10 days

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026